About the Plant-Based Vaccines Session
Plant-based vaccines represent an innovative approach to vaccine development, utilizing plants as bioreactors for producing antigens. This method harnesses the natural ability of plants to synthesize complex proteins, enabling the mass production of vaccine components that can stimulate an immune response. Plant-derived vaccines offer several advantages, including ease of production, cost-effectiveness, and stability at ambient temperatures, which is crucial for distribution in developing regions. Additionally, the use of plants minimizes the risk of contamination associated with traditional vaccine production methods. Research is ongoing to optimize the efficacy and delivery of these vaccines, with the potential to combat diseases in both humans and animals.
Topics Covered in Plant-Based Vaccines
Antigen expression in plant tissue
Edible and oral vaccine concepts
Adjuvants and immune response
Dose consistency and stability
Preclinical and clinical testing
Regulatory pathway for plant vaccines
Featured Speakers — Plant-Based Vaccines 2027
Speaker lineup for this track will be announced soon.
Browse all speakers →Recent Research Presented at Plant-Based Vaccines Sessions
Selected abstracts from this track will be published here.
Related Scientific Sessions at GPB 2027
Why Attend the Plant-Based Vaccines Conference 2027
Earn CPD Credit
Sessions are CPD-accredited — earn 1 CPD credit for each hour of attendance.
Present Your Research
Oral and poster slots for original Plant-Based Vaccines work, reviewed by the scientific committee.
Network Globally
Meet plant scientists, breeders, biotechnologists and crop researchers from around the world across three days.
Featured in the Abstract Book
Accepted abstracts are collected in the conference abstract book, published for every edition.
Learn from Keynotes
Plenary lectures from leading voices shaping Plant-Based Vaccines research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join GPB 2027 for the Plant-Based Vaccines track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Plant-Based Vaccines Conference 2027 — FAQs
What is the Plant-Based Vaccines track at GPB 2027?
The Plant-Based Vaccines track is a dedicated stream within GPB 2027 covering the latest research, clinical innovation, and best practice in Plant-Based Vaccines. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Plant-Based Vaccines sessions?
Plant scientists, breeders, biotechnologists, agronomists, doctoral students, and research leaders with an interest in Plant-Based Vaccines are all welcome — whether presenting or attending.
Can I present my research in the Plant-Based Vaccines track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Plant-Based Vaccines sessions?
Yes. GPB 2027 is a hybrid conference — attend the Plant-Based Vaccines track in person in Singapore or join live online, with on-demand access afterward.
Join the GPB 2027 delegation
Singapore · March 18–20, 2027· Hybrid · in-person & virtual
Attend without presenting.